Abstract: The host defense mechanism in chromoblastomycosis has not been thoroughly investigated. It has been suggested that cell-mediated immunity in patients with long-standing chromoblastomycosis is somehow impaired. As a result, these individuals became unable to develop an efficient immune reaction. Many studies have shown that monocyte-derived macrophages exhibit critical activities in immunity to microorganisms. Moreover, the ability of cells from the monocytic lineage to process and present antigens, to produce cytokines, and to provide costimulatory signals confirms their pivotal role in the initiation of specific immune responses. In the present study, it was observed that monocytes from patients with a severe form of disease had a higher production of IL-10 and a lower expression of HLA-DR and costimulatory molecules when stimulated with specific antigen or LPS. Immune modulation with recombinant IL-12 or anti-IL-10 can restore the antigen-specific Th1-type immune response in chromoblastomycosis patients by up-regulating HLA-DR and costimulatory molecules in monocytes. Therefore, our data show that monocytes from patients with different clinical forms of chromoblastomycosis present distinct phenotypic and functional profiles. This observation suggests possible mechanisms that control the T cell response and influence their role in the development of pathology. J. Leukoc. Biol. 84: 000 -000; 2008.
INTRODUCTION
Chromoblastomycosis is a human chronic fungal disease usually limited to s.c. tissues. Infection is initiated by traumatic inoculation of mycelium fragments or conidial cells into the skin by thorns or wood splinters [1] . Chromoblastomycosis usually affects male agricultural workers who are not adequately protected while handling soil and vegetables and decomposing organic matter, which are natural habitats of the fungus [2, 3] . It occurs worldwide but is observed more frequently in tropical countries such as Brazil [4, 5] . This mycosis is caused by several species of dematiaceous hyphomycetes: Fonsecaea pedrosoi, Phialophora verrucosa, Cladophialophora carrionii, and Rhinocladiella aquaspersa [6] . F. pedrosoi is considered its most frequent etiologic agent in Brazil. Clinically, chromoblastomycosis is characterized by a slow development of polymorphic skin lesions, where there are usually erythematous papules, which enlarge gradually to display varying morphologies (nodules, verrucas, plaques, and scar tissue) [6] . Inside the host, infectious propagules adhere to epithelial cells and differentiate into sclerotic forms, which effectively resist destruction by host effector cells and allow chronic disease to establish. The disease is usually insidious, and the lesions increase slowly but progressively, not responding to the usual treatments and reappearing quite often.
The host defense mechanism in chromoblastomycosis was not thoroughly investigated. Some studies have focused on fungus-host interaction, showing a predominant, cell-mediated immune response, with activated macrophages involved in fungal phagocytosis [7, 8] . It has been suggested that cellmediated immunity in patients with long-standing chromoblastomycosis is somehow impaired. As a result, these individuals became unable to develop an efficient immune response to fungal antigens, contributing to persistence of fungus in the tissue [9] .
Recently, we showed a high production of IL-10 and low levels of IFN-␥ after stimulation with a specific antigen in humans with severe forms of disease [8] . T cells from these individuals fail to proliferate in vitro after induction with chromoblastomycosis antigen (chromoAg). In contrast, patients with mild forms of the disease predominantly produce IFN-␥ and low levels of IL-10, together with an efficient proliferation of T cells. These results indicate that T cells secreting IFN-␥ are required to induce protective immunity against F. pedrosoi [8, 10] . The factors that determine different clinical outcomes leading to a mild or severe form are not completely understood. However, it is clear that chromoblastomycosis pathology is associated with host immune response.
Regarding clinical evolution and characteristics of the infection, we hypothesize that monocytes from patients with severe chromoblastomycosis display anti-inflammatory characteristics, as opposed to monocytes from patients with mild disease. To test this hypothesis, we assessed the ex vivo expression of surface molecules involved in T cell activation (HLA-DR, CD80, and CD86) and key immunoregulatory cytokines (IL-10, IL-12, and TNF-␣) produced by monocytes from both patient groups. Our data show that monocytes from patients with different clinical forms of chromoblastomycosis display distinct phenotypic and functional characteristics, suggesting possible mechanisms for control of responses of T cells and influencing their role in the development of pathology.
MATERIALS AND METHODS

Patients
Sixteen patients with clinical diagnosis of chromoblastomycosis attended at the Department of Pathology of the Federal University of Maranhão (Brazil) were included in this study. In all cases, diagnosis was confirmed by direct mycological examination, culture, and histopathogy. In all cases, the fungus F. pedrosoi was isolated.
Chromoblastomycosis lesions were classified according to Carrion [11] , and severity of the disease was classified according to number, extension, and dissemination of the lesions as described by Queiroz-Telles et al. [12] . Briefly, the mild form was defined as a solitary plaque or nodular lesion of less than 5 cm diameter. The severe forms were characterized by lesions, including those of the tumoral and cicatricial types, covering extensive cutaneous regions. The patients were grouped according to the severity of chromoblastomycosis: eight patients with a mild form (six males and two females; age range: 40 -70 years) and eight with a severe form (six males and two females; age range: 49 -92 years) of the disease. Healthy individuals (nine individuals: seven males and two females; age range: 35-75 years) living in a nonendemic area for chromoblastomycosis (São Paulo City, Brazil) were used as the controls.
Fungal antigen
F. pedrosoi (ATCC 46428) were grown in Sabouraud medium (15 days; 37°C) with constant agitation. The culture was filtered, and the supernatant was used as the chromoAg. Protein concentration was determined by the Bradford method [13] . Contamination of the cultures with LPS was monitored using the Limulus amebocyte lysate (LAL) test (Endosafe LAL, Charles River, Charleston, SC, USA). Maximal concentration of LPS detected in the cultures was always Ͻ0.1 ng LPS/ml.
Isolation of monocytes
PBMCs were isolated by centrifugation over Ficoll-Hypaque (400 g; 30 min). The phase containing white cells was removed and washed (RPMI 1640). For positive selection of CD14 ϩ monocytes, PBMCs were mixed with anti-human CD14 antibody-conjugated microbeads (BD Biosciences, San Jose, CA, USA). CD14 ϩ monocytes were separated from other cells by using a magnetic separation column under a magnetic field (Miltenyi Biotec, Auburn, CA, USA), according to the manufacturer's instructions, and washed thoroughly to remove any nonspecific binding to the beads. CD14 ϩ cells were then eluted with 2% FCS in PBS. The isolated cells were more than 95% CD14 ϩ as evaluated by FACS analysis.
Isolation of CD4ϩ T cells
Isolation of CD4ϩ T cells was performed using the immunomagnetic, positive separation technique with anti-human CD4 antibody-conjugated microbeads as described above. The isolated cells were more than 90% CD3 ϩ CD4 ϩ as evaluated by FACS analysis.
Analysis of expression of surface molecules by monocytes and production of cytokines
The effects of F. pedrosoi on the expression of surface molecules by monocytes were investigated using monocytes incubated (4 h) with chromoAg (40 g/ml) or LPS (10 ng/ml). Monocyte phenotypes were analyzed by flow cytometry with a FACScan flow cytometer (Becton Dickinson, San Diego, CA, USA). To determine the expression of HLA-DR and costimulatory molecules, PE-labeled mAb were used against CD80 and CD86 or isotype controls. The percent ratio between positive cells and mean of fluorescence intensity (MFI) obtained with specific antibodies was calculated. Supernatants from cultures of monocytes stimulated with chromoAg or LPS were evaluated for IL-10, IL-12, and TNF-␣ by ELISA, according to the manufacturer's instructions (BD PharMingen, San Diego, CA, USA).
Analysis of expression of costimulatory molecules in CD4-T lymphocytes from chromoblastomycosis patients and noninfected individuals
The surface expression of CD28, receptor ␤ chain of IL-12 (CD202), and CTLA-4 in T lymphocytes from individuals of different groups were evaluated. To access the ex vivo expression of these molecules in each group, analyses were performed in cells cultured in the absence of any stimulus.
PBMCs were incubated with PE-labeled anti-CD28, anti-CTLA-4, or anti-CD202 mAb in conjunction with FITC-labeled anti-CD4 mAb and analyzed by flow cytometry.
Proliferation assay
Monocytes (5ϫ10 5 cell/ml) were cultured (4 days) with CD4ϩ T cell (2ϫ10 6 cells/ml) in the presence of chromoAg (40 g/ml) in 96-well plates. The cultures were then pulsed with [ 3 H]-thymidine (Amersham Pharmacia Biotech, UK; 1 mCi/well; 16 h), harvested, and quantified using standard liquid scintillation-counting techniques.
Cytokine quantitation
Monocytes (5ϫ10 5 cell/ml) and CD4ϩ T cells (2ϫ10 6 cells/ml) were added onto 24-well plates (48 h) with (40 g/ml) or without chromoAg. The supernatants were collected and assayed for IFN-␥ cytokine by ELISA, according to the manufacturer's instructions. IL concentrations were determined by using curves with serial dilutions of recombinant human (rh)IFN-␥.
Modulation of proliferation by IL-12 and anti-IL-10
To determine the role of cytokines in proliferative response and cytokine production, monocytes and CD4 T cells were incubated as described above in the presence of rhIL-12 or a neutralizing anti-IL-10 mAb. IL-12 (1 ng/mL) was added in the first day of culture, and its concentration was determined to be optimal in previous dose-response experiments (0.1-10 ng/mL) with cells from four patients (data not shown). A rat anti-human IL-10 mAb (IgG1, 10 ng/mL) was added at Day 0 of the cultures. This dose completely neutralized the cytokine, as determined by ELISA. An irrelevant rat anti-IgG1 mAb (Becton Dickinson) was used in some experiments as an isotype-matched control and showed no effect on the proliferative or IFN-␥ responses. To determine the expression of surface molecules after proliferation of monocytes, the cells were collected on the 4th day of culture and stained by incubation with PE-labeled anti-CD80, -CD86, or -HLA-DR mAb in conjunction with FITC-labeled anti-CD14 mAb and analyzed by flow cytometry.
Statistical analysis
Statistical comparisons were performed using the Kruskal-Wallis nonparametric test. Significance was defined as P Ͻ 0.05.
RESULTS
Ex vivo analysis of the expression of costimulatory molecules and production of cytokines by monocytes from patients with different forms of chromoblastomycosis
To determine whether there were differences in the expression of molecules biologically relevant for monocyte function (such as antigen presentation), expression of CD80, CD86, and HLA-DR by CD14 cells from mild and severely infected patients or noninfected individuals was evaluated. Frequencies as well as intensities of expression of each molecule by the CD14 monocyte population were analyzed. Our analysis demonstrated that the frequency of expression of CD80, CD86, and HLA-DR molecules by CD14 cells and the intensity of expression of these molecules within the CD14 subset were higher in patients with a mild form of infection when compared with frequencies and intensities in patients with a severe form with no stimulus in vitro (Fig. 1, media) . When chromoAg or LPS was used as stimuli in vitro, monocytes from patients with a mild form of infection exhibited increased expression of CD80 and HLA-DR molecules, but no differences were observed in the expression of monocytes from patients with severe forms of infection (Fig. 1) .
To determine whether in vitro stimulation would lead to changes in the profile of cytokines produced by monocytes from chromoblastomycosis patients and noninfected individuals and/or patients with different clinical forms of infection, production of IL-10, IL-12, and TNF-␣ by these cells was evaluated by ELISA. It was observed that stimulation of CD14 cells from patients with a mild form of infection caused a production of TNF-␣ and IL-12 higher than that displayed by patients with the severe forms. In contrast, monocytes from patients with severe forms of infection produced higher levels of IL-10 when compared with monocytes from patients with the mild form (Fig. 2) .
Ex vivo analysis of the expression of costimulatory molecules by CD4ϩ T cells from patients with different forms of chromoblastomycosis
Our results showed that patients with different forms of chromoblastomycosis expressed similar levels of CD28, CTLA-4, and CD202 molecules. An increase in CTLA-4 expression was observed in cells from patients with the severe form of disease. However, this difference was not significant (Fig. 3) .
Proliferation of CD4 T cells from patients with different forms of chromoblastomycosis in the presence of anti-IL-10 mAb or rIL-12
We showed above that monocytes from patients with the severe form of chromoblastomycosis expressed lower levels of costimulatory molecules and produced higher levels of IL-10. To analyze whether this defective expression of costimulatory molecules could affect T cell activation, proliferation assays were performed. Our results showed that cells from patients with the severe form of disease (chromoAg) presented lower proliferation (Fig. 4) . Thereafter, we analyzed whether a high level of IL-10 and a low production of IL-12 could influence T cell proliferation. Our results showed that addition of anti-IL-10 or rIL-12 in the culture significantly increased proliferation of cells from patients with the severe form of chromoblastomycosis (Fig. 4) . Addition of anti-IL-10 mAb plus rIL-12 did not result in significantly improved proliferation when compared with isolated additions (data not shown).
Production of IFN-␥ by T cells from patients with the severe form of chromoblastomycosis in the presence of anti-IL-10 mAb or rIL-12
To test the hypothesis that high production of IL-10 associated with low levels of IL-12, as observed in these patients, could contribute to a defective production of IFN-␥, first, IL-10 was blocked, and second, rIL-12 was added to the culture. Our results showed that both treatments induced increased production of IFN-␥ by T cells from patients with the severe forms of chromoblastomycosis (Fig. 5) . A significant increase in the production of IFN-␥ by cells from patients with the mild form of disease was also observed (data not shown).
Expression of costimulatory molecules by monocytes after lymphoproliferation in the presence of anti-IL-10 mAb or rIL-12
To determine whether the proliferation observed in the presence of anti-IL-10 mAb or rIL-12 could be mediated by increased expression of costimulatory molecules by monocytes, cells were analyzed for expression of CD14 ϩ in conjunction with CD80, CD86, and HLA-DR after 4 days of specific stimulus. A significant increase in the percent ratio of monocytes expressing CD80, CD86, and HLA-DR was observed when anti-IL-10 mAb or rIL-12 were added to the culture (Fig.  6) . The costimulatory molecules on CD4 T cells were analyzed, Fig. 2 . Cytokine production by monocytes of patients with different forms of chromoblastomycosis. Monocytes were purified and stimulated with chromoAg (40 g/ml) or LPS (10 ng/ml), and after 4 h, the supernatant was harvested and cytokine determined. The results are representative of three independent experiments. *, P Ͻ 0.05, when compared with control (media). Fig. 3 . Ex vivo analysis of costimulatory molecules CD28, CTLA-4, and CD202 expression by CD4ϩ lymphocytes from mild and severe patients and noninfected individuals. Cells were double-stained for costimulatory molecules CD28, CTLA-4, and CD202 and CD4 expression and analyzed by flow cytometry, as described in Materials and Methods. Results are expressed as percentages of CD4ϩ lymphocytes expressing CD28, CTLA-4, or CD202. The results are representative of three independent experiments, where the blood was collected from each study subjects at three different times. No significant differences were observed in the variability intra-subject regarding lymphocyte phenotype when comparing samples collected on different days [for example, percentage of CD28 expression on the CD4ϩ lymphocyte from a mild-form patient ranged from 55% (first days of collect) to 52% (third collect)]. *, P Ͻ 0.05, when compared with control (N.I.). but no significant differences were observed in the expression of CD28, CTLA-4, and CD202 before and after proliferation (data not shown).
DISCUSSION
Many studies have demonstrated that monocyte-derived macrophages display critical activities in immunity to microorganisms. The encounter of differentiated monocytes with microorganisms is an essential step in the initial control of infections [14] . The differential ability of pathogens to interact with macrophages is likely to determine whether Th1 or Th2 cells will develop preferentially to bias the adaptive immune response, resulting in elimination or survival of the pathogen within the host.
We demonstrated herein that monocytes from all patients with chromoblatomycosis were more active than those from the controls. However, monocytes purified from patients with the severe form of disease expressed lower levels of HLA-DR and costimulatory molecules than those from patients with the mild form. Indeed, monocytes from patients with severe forms of disease produced IL-10 and IL-12 at levels that were, respectively, higher and lower than cells from patients with the mild form of disease when stimulated with chromoAg or LPS.
As shown for other diseases [15] [16] [17] , a number of factors may regulate resistance or susceptibility. Dose of antigen, APCs, and the costimulatory microenvironment are some of the factors postulated as polarizing ones in determining the preferential immune response pathway to be activated [18, 19] . The lower level of HLA-DR expression in combination with high production of IL-10 observed by us in patients with severe forms of disease is likely to be involved in an inappropriate T cell activation and consequently, in susceptibility to infection. The higher levels of IL-10 in cells from severe patients could explain the lower levels of HLA-DR and costimulatory expression found in their monocytes. Moreover, these results indicate that interaction of fungi with monocytes from mild patients induces a cascade of reactions that causes the production of The results are representative of three independent experiments. As a control, only media or media in the presence of anti-IL-10 or rIL-12 were used. *, P Ͻ 0.05, when compared with control (chromoAg). inflammatory cytokines, whereas in an interaction of fungi with cells from severe patients, the balance is tipped toward the production of anti-inflammatory cytokines. We also analyzed the costimulatory molecules on T cells, but no differences were observed between mild and severe forms of disease, indicating that this via was not affected in the chromoblastomycosis.
To assess a possible influence of IL-12 or IL-10 on T cell activation, a proliferation assay was performed in the presence of anti-IL-10 mAb or rIL-12. It was observed that in vitro addition of rIL-12 can restore lymphoproliferation and production of IFN-␥, mainly in patients with severe forms of disease. A similar increase was also observed by neutralizing endogenous IL-10. It is interesting that a combination of treatments in vitro caused neither any increase in lymphocyte proliferation nor IFN-␥ production.
It was shown that addition of rIL-12 or neutralization of IL-10 by mAb restored lymphocyte proliferation and production of IFN-␥ by PBMCs from patients with active leishmaniasis [20] . Romano et al. [21] published a similar result, where these authors showed that addition of rIL-12 and neutralization of endogenous IL-10 could revert the in vitro antigen-specific, cellular immunosuppression of paracoccidioidomycosis patients. These data indicate that combination immunotherapy, in which antagonists of "negative" regulatory cytokines are used, may be a more effective strategy in combating human infectious disease [22, 23] .
In the present study, we showed that re-establishment of proliferation was mediated, at least in part by an increase in HLA-DR and costimulatory molecules in monocytes. It is likely that a block of IL-10 or high concentration of IL-12 could modify the expression of HLA-DR and costimulatory molecules in monocytes inducing activation of IFN-␥-producing Th1 cells. Therefore, the presence of IFN-␥ produced by recently activated Th1 cells could induce an increase in HLA-DR and costimulatory molecules in monocytes.
In conclusion, our results indicate that changes in the expression of costimulatory molecules and cytokine production in monocytes could be an important mechanism for the establishment of pathogenic versus protective responses in chromoblastomycosis. However, it is clear by us that other mechanisms, not studied in this work, could also participate in this process. 
